Youngevity (NASDAQ:YGYI) has reached another milestone in its CBD business by announcing its intent to launch CBD coffee in May of this year. Creating a CBD coffee that is dose-specific and can survive the filtration process of coffee brewing has been a struggle for many entrepreneurs within the hemp and CBD space.
The event that set the stage for this to happen was the acquisition of Khrysos Industries which included INX Labs. The capabilities procured with this acquisition, combined with Youngevity’s experience with its already established CLR Roasters, have allowed the company to be at the forefront of CBD coffee. Youngevity sells at both retail and direct selling. The direct selling component provides a built-in consumer base for the sale of products.